These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2681766)

  • 1. A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers.
    Brandt KD
    J Rheumatol Suppl; 1989 Aug; 18():39-42. PubMed ID: 2681766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cartilage breakdown in equine osteoarthritis: measurement of keratan sulphate by an ELISA system.
    Alwan WH; Carter SD; Bennett D; May SA; Edwards GB
    Res Vet Sci; 1990 Jul; 49(1):56-60. PubMed ID: 1696390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the role of molecular markers to monitor disease, intervention, and cartilage breakdown in osteoarthritis.
    Lohmander LS; Felson DT
    J Rheumatol; 1997 Apr; 24(4):782-5. PubMed ID: 9101518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating keratan sulfate: a marker of cartilage proteoglycan catabolism in osteoarthritis.
    Thonar EJ; Manicourt DM; Williams J; Lenz ME; Sweet MB; Schnitzer TJ; Otten L; Glant T; Kuettner KE
    J Rheumatol Suppl; 1991 Feb; 27():24-6. PubMed ID: 2027120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of keratan sulfate in blood as a marker of cartilage catabolism.
    Thonar EJ; Schnitzer TJ; Kuettner KE
    J Rheumatol; 1987 May; 14 Spec No():23-4. PubMed ID: 2957502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degenerated human articular cartilage at autopsy represents preclinical osteoarthritic cartilage: comparison with clinically defined osteoarthritic cartilage.
    van Valburg AA; Wenting MJ; Beekman B; Te Koppele JM; Lafeber FP; Bijlsma JW
    J Rheumatol; 1997 Feb; 24(2):358-64. PubMed ID: 9034997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological markers of osteoarthritis].
    Thonar EJ; Manicourt DH
    Rev Rhum Ed Fr; 1994 Nov; 61(9 Pt 2):99S-102S. PubMed ID: 7858614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
    Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
    Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid glycosaminoglycan concentration does not correlate with severity of chondropathy or predict progression of osteoarthritis in a canine cruciate deficiency model.
    Myers SL; Brandt KD; Albrecht ME
    J Rheumatol; 2000 Mar; 27(3):753-63. PubMed ID: 10743821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
    Manicourt DH; Altman RD; Williams JM; Devogelaer JP; Druetz-Van Egeren A; Lenz ME; Pietryla D; Thonar EJ
    Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
    Brandt KD; Slowman-Kovacs S
    Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoarthritis in the temporo-mandibular joint (TMJ) of aged mice and the in vitro effect of TGF-beta 1 on cell proliferation, matrix synthesis, and alkaline phosphatase activity.
    Livne E; Laufer D; Blumenfeld I
    Microsc Res Tech; 1997 May; 37(4):314-23. PubMed ID: 9185153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical markers of bone turnover. New aspect. Biomarkers of cartilage metabolism].
    Okano T; Koike T
    Clin Calcium; 2009 Aug; 19(8):1149-58. PubMed ID: 19638699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum markers of systemic disease processes in osteoarthritis.
    Thonar EJ; Masuda K; Lenz ME; Hauselmann HJ; Kuettner KE; Manicourt DH
    J Rheumatol Suppl; 1995 Feb; 43():68-70. PubMed ID: 7752142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin as a marker for osteoarthritis.
    Lust G; Burton-Wurster N; Leipold H
    J Rheumatol; 1987 May; 14 Spec No():28-9. PubMed ID: 3625673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.